Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$501000.0.

  • Centessa Pharmaceuticals' Exchange Rate Effect rose 7368.7% to -$501000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $901000.0, marking a year-over-year increase of 13902.12%. This contributed to the annual value of $1.2 million for FY2024, which is 9951.22% up from last year.
  • Centessa Pharmaceuticals' Exchange Rate Effect amounted to -$501000.0 in Q3 2025, which was up 7368.7% from -$113000.0 recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Exchange Rate Effect high stood at $3.0 million for Q4 2024, and its period low was -$1.9 million during Q3 2024.
  • Moreover, its 4-year median value for Exchange Rate Effect was -$120000.0 (2024), whereas its average is -$47133.3.
  • Examining YoY changes over the last 5 years, Centessa Pharmaceuticals' Exchange Rate Effect showed a top increase of 70158.73% in 2024 and a maximum decrease of 96545.45% in 2024.
  • Quarter analysis of 4 years shows Centessa Pharmaceuticals' Exchange Rate Effect stood at $722000.0 in 2022, then crashed by 169.81% to -$504000.0 in 2023, then skyrocketed by 701.59% to $3.0 million in 2024, then tumbled by 116.52% to -$501000.0 in 2025.
  • Its Exchange Rate Effect was -$501000.0 in Q3 2025, compared to -$113000.0 in Q2 2025 and -$1.5 million in Q1 2025.